HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

68Ga-SB3

a gastrin-releasing peptide receptor antagonist; structure in first source

Also Known As:

68Ga-DOTA-p-aminomethylaniline-diglycolic acid-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Maina, Theodosia: 3 articles (11/2021 - 01/2017)
2.	Nock, Berthold A: 3 articles (11/2021 - 01/2017)
3.	de Jong, Marion: 3 articles (11/2021 - 01/2017)
4.	Kaloudi, Aikaterini: 2 articles (03/2019 - 01/2017)
5.	Krenning, Eric P: 2 articles (03/2019 - 01/2017)
6.	Lymperis, Emmanouil: 2 articles (03/2019 - 01/2017)
7.	Bakker, Ingrid L: 1 article (11/2021)
8.	Busstra, Martijn B: 1 article (11/2021)
9.	Dalm, Simone U: 1 article (11/2021)
10.	Fröberg, Alida C: 1 article (11/2021)

Related Diseases

1.	Neoplasms (Cancer) 11/01/2021 - "The aims of this phase I study were to investigate 68Ga-SB3 PET/CT imaging of primary PCa tumors and assess safety. " 01/01/2017 - "We recently introduced the potent gastrin-releasing peptide receptor (GRPR) antagonist 68Ga-SB3 (68Ga-DOTA-p-aminomethylaniline-diglycolic acid-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt), showing excellent tumor localizing efficacy in animal models and in patients. "
2.	Prostatic Neoplasms (Prostate Cancer) 03/13/2019 - "Background: The GRPR-antagonist 68Ga-SB3 visualized prostate cancer lesions in animal models and in patients. " 11/01/2021 - "GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients."
3.	Prostatic Intraepithelial Neoplasia 11/01/2021 - "68Ga-SB3 PET/CT imaging showed uptake in 2 large prostatic intraepithelial neoplasia foci, considered a precursor to PCa, resulting in an 88% specificity. "

Related Drugs and Biologics

1.	Bombesin Receptors (Bombesin Receptor)

Related Therapies and Procedures

1.	Therapeutics